Express Scripts, the nation’s largest national Pharmacy Benefit Management Service (PBMS), has dropped Zohydro ER from its 2015 formulary of covered medications. Insured patients whose…
Six months after the introduction of Zohydro, there have been no confirmed cases of diversion, overdose or death caused by the controversial painkiller, according to…
Sales of Zohydro – a controversial new hydrocodone painkiller – are growing steadily, despite efforts in some states to ban or restrict the prescribing of…
A controversial new painkiller is no more powerful or addictive than other opioid medications already on the market and pain patients should have access to…
A federal judge in Boston has ruled that an unprecedented ban on the sale of a controversial new painkiller in Massachusetts is unconstitutional. Despite the…
An unprecedented ban on a controversial new painkiller remains in effect in Massachusetts, after a federal judge in Boston heard arguments in a lawsuit by…